Health Condition 1: M266- Temporomandibular joint disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients clinically diagnosed with TMD as per the latest version of RDC or TMD. 2.Patients willing to participate who have given consent for the study. 3. Patients with blood parameters (CBC, RA Factor and Uric Acid) levels within normal limits.
Exclusion criteria
Exclusion criteria: 1.Subjects with history of orthodontic or prosthodontic treatment. 2.Subjects with history of trauma or surgery of the TMJ. 3.Subjects with history of previous treatment for the same complaint. 4. Subjects with OPG showing degenerative changes in the mandibular condyle e.g. rheumatoid arthritis, osteoarthritis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical assessments of Pain intensity using the Visual Analog Scale and Jaw functional limitation using the Jaw Functional Limitation Scale will be done preoperatively by a trained observer. Timepoint: Baseline, 4 week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate changes in neural activity in key pain-related brain regions (e.g., anterior cingulate cortex, insula, prefrontal cortex) following LLLT treatment in TMD patients. 2.To assess the impact of LLLT on functional connectivity within pain-processing networks, including the default mode network and salience network. 3.To correlate neural changes with clinical pain scores and functional improvement in TMJ disorders. Timepoint: Baseline , 4 Week | — |
Countries
India
Contacts
Institute of medical sciences, Banaras Hindu University